U.K. Insurance Stock News

How Rio Tinto Group (LSE:RIO) Has Been Performing With no single headline event driving attention, Rio Tinto Group (LSE:RIO) is drawing interest on the back of its recent share performance and financial profile across iron ore, aluminium and copper operations. The share price recently closed at £73.91, with a return of 0.6% over the past day, 0.1% over the past week, about 4.1% over the past month and roughly 9.7% over the past 3 months. Year to date, the stock shows a total return of about...

If you are wondering whether BP's current share price reflects its true worth, you are not alone. The stock has drawn plenty of attention from value focused investors. Over the past year BP has returned 72.9%, with a 30.6% return year to date, even though the last 30 days show a 3.3% decline and the past week was flat at 0.0%. Recent news around BP has focused on its position in the global energy sector and how its mix of traditional and lower carbon assets fits into investors' portfolios...

Admiral Group plc ( LON:ADM ) is about to trade ex-dividend in the next three days. The ex-dividend date is usually set...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see ME Group...

Standard Chartered PLC ( LON:STAN ) just released its latest first-quarter results and things are looking bullish. It...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Even if it's not a huge purchase, we think it was good to see that Nicholas Shott, the Independent Non-Executive...

If you are wondering whether AstraZeneca shares still offer value after a strong run, this article walks through what the current price really implies. The stock last closed at £135.12, with returns of 27.8% over 1 year and 94.1% over 5 years, alongside shorter term moves of a 3.2% decline over 7 days, an 11.8% decline over 30 days, and a 0.6% decline year to date. Recent coverage has focused on AstraZeneca's role as a major pharmaceuticals group listed in London and how market expectations...

Glencore at a glance Glencore (LSE:GLEN) has been drawing attention after a year total return of 131% and a year to date return of 38%. This has prompted investors to reassess how this diversified commodities group fits into their portfolios. See our latest analysis for Glencore. Glencore’s £5.63 share price sits on the back of a 12.77% 90 day share price return and a 130.95% total shareholder return over the past year, suggesting positive momentum despite a small 1 day pullback. If you are...

GSK (LSE:GSK) and Alector have ended their Alzheimer’s drug partnership after repeated clinical failures. The decision follows lack of efficacy in key trials within a major neurodegeneration program. Separately, GSK has halted an external antibody drug conjugate collaboration following clinical issues and FDA holds. The company is now concentrating on internally developed and in licensed antibody drug conjugates for oncology. For readers tracking LSE:GSK, this marks a clear change in how...

What recent performance says about Diageo (LSE:DGE) Diageo (LSE:DGE) has drawn fresh attention after a mixed share performance, with a gain over the past month set against weaker returns in the past 3 months and over the past year. See our latest analysis for Diageo. At the current share price of £14.81, Diageo’s 30 day share price return of 6.15% sits against a 1 year total shareholder return of 27.49% and a 3 year total shareholder return of 55.56% decline. This points to fading longer term...

Rio Tinto Group (LSE:RIO) has entered a new gold and copper exploration joint venture in Montana through its Kennecott unit with Mogotes Metals. The partnership targets early stage exploration in the US, expanding Rio Tinto's footprint in North American precious and base metals. Top tier analysts at Goldman Sachs and Macquarie have recently highlighted Rio Tinto's gold and aluminium exposure in their outlooks. Rio Tinto is known primarily for iron ore, aluminium and copper, so fresh gold...

Whilst it may not be a huge deal, we thought it was good to see that the River Global Plc ( LON:RVRG ) Executive...

Investors who take an interest in Hikma Pharmaceuticals PLC ( LON:HIK ) should definitely note that the Independent...

RELX PLC ( LON:REL ) stock is about to trade ex-dividend in 4 days. The ex-dividend date is commonly two business days...

Recent share performance and key context AstraZeneca (LSE:AZN) has drawn investor attention after a recent share price slide, with the stock showing a 3.1% decline over the past week and a 10.1% decline over the past month. See our latest analysis for AstraZeneca. The recent 10.1% 1 month share price decline sits in contrast to AstraZeneca's 27.84% 1 year total shareholder return. This suggests recent momentum has faded even as longer term holders have still seen strong compounded gains. If...

BP (LSE:BP.) is reportedly reviewing its North Sea oil and gas portfolio in response to UK windfall taxes. New CEO Meg O’Neill is said to have ordered a broad review of BP’s UK offshore operations. The review includes consideration of a potential withdrawal from the North Sea and a possible move of the company’s stock market listing to the US. BP operates as a global energy group with interests across oil, gas and lower carbon businesses, and the North Sea has historically been an important...

Shell has agreed to acquire Canadian producer ARC Resources, in its largest deal in more than a decade. The transaction is aimed at expanding Shell's liquefied natural gas and North American gas operations. The move comes during ongoing global energy supply disruptions linked to conflicts in the Middle East. LSE:SHEL is trading at around £32.9, with the share price up 19.2% year to date and 37.6% over the past year. Over a 5 year period, the stock is up 180.3%, which puts recent news in the...

Rolls-Royce Holdings reported that Trent XWB engine flying hours have returned to pre war levels. The company reaffirmed its profit and cash flow guidance, indicating no change to current financial expectations. The update focuses on the widebody engine segment, a core part of Rolls-Royce's civil aerospace business. For investors following LSE:RR., this update comes after a very strong share price move over the past 3 years, with the stock up roughly 7x and also higher by 54.3% over the...

If you are wondering whether Glencore’s current share price still offers value, the key is to look closely at what the market is paying for its fundamentals. With the share price at £5.678 and returns of 0.9% over 7 days, 0.4% over 30 days, 38.9% year to date and 135.2% over 1 year, many investors are reassessing what is already priced in. Recent headlines around Glencore have kept attention on the stock, as investors weigh how company specific developments and sector sentiment relate to...

How Unilever’s Recent Performance Frames the Investment Question Unilever (LSE:ULVR) has drawn fresh investor attention after a mixed run in its share performance, with a modest gain over the past month contrasted by a double digit decline over the past 3 months. Against that backdrop, the group’s current valuation, recent total returns and headline financials offer a snapshot of how this global consumer goods business is currently being priced in the market. See our latest analysis for...

The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices closing lower amid concerns over weak trade data from China, highlighting global economic uncertainties. For investors considering smaller or newer companies, penny stocks—despite their somewhat outdated label—remain an intriguing area of investment. These stocks can offer a blend of value and growth potential when supported by strong financial fundamentals, making them worth watching for those seeking...

Considering whether GSK’s share price still offers value after a strong run, or if most of the upside is already reflected in the stock. GSK’s share price was £19.29 at the last close, with a 37.2% return over 1 year, 48.2% over 3 years and 75.6% over 5 years. This is despite a 7.1% decline over the past week and a 6.6% decline over the past month, while year to date the stock is up 5.3%. Recent price moves have come alongside ongoing attention on GSK’s product portfolio and pipeline, as...

Amidst a challenging landscape where the FTSE 100 has recently faltered due to weak trade data from China, investors are keenly observing opportunities that may arise from undervalued stocks in the United Kingdom. In such a climate, identifying stocks like Mitie Group and others that offer potential value can be crucial for those looking to navigate market uncertainties and capitalize on long-term growth opportunities.